HeyJaredSheila Jacobs
- Indexed articles, last 90 days
- 16
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Renal and Urology News
- Top 5M sites
- Earliest in this view
- Jul 10, 2026
Latest articles
Case Report: Overlapping Autoimmune Disorders Linked to Chronic Hydralazine Therapy (opens the original)
Read excerpt
A 71-year-old man presented with a large circumferential pericardial effusion and multiorgan failure in the setting of chronic hydralazine use, according to a case study published recently in JACC: Case Reports. The male patient, who had a history of chronic myelomonocytic leukemia, uncontrolled hypertension, and chronic kidney disease, was admitted to the hospital because of abdominal pain, diarrhea, and vomiting of 3 weeks’ duration. On day 17 of hospitalization, he developed acute hypoxic res
Rare Case Study: MPA Subtype of MPO-AAV With Severe Pulmonary-Renal Relapse (opens the original)
Read excerpt
A 66-year-old Ecuadorian woman with the microscopic polyangiitis (MPA) subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) experienced a sudden, severe disease relapse in which both her lungs and kidneys were affected, according to a case study published recently in Frontiers in Medicine. The patient, who had a history of myeloperoxidase (MPO)-AAV with prior renal-pulmonary involvement, was admitted to a hospital in Quito, Ecuador, because of acute respiratory failu
Subgroup of Relapsing Patients With AAV Show Suboptimal Rituximab Response (opens the original)
Read excerpt
A small clinical subgroup of patients with relapsing antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has been described who exhibit a suboptimal response to rituximab therapy, according to findings from a post hoc analysis of the international, randomized, open-label RITAZAREM trial (NCT01697267) published recently in Frontiers in Medicine. The researchers evaluated the characteristics, frequency, and outcomes of a suboptimal response to rituximab among certain patients wi
AION: Rare, Severe Initial EGPA Presentation Warrants Immediate Immunosuppression (opens the original)
Read excerpt
A rare, severe initial manifestation of the eosinophilic granulomatosis with polyangiitis (EGPA) subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has been reported in a Japanese woman, according to a case report published recently in Modern Rheumatology Case Reports. The unusual disease presentation, which was ultimately recognized as being anterior ischemic optic neuropathy (AION), involved sudden, painless vision loss in the patient’s left eye. Patients with AI
Capture-Recapture Study Finds High Prevalence of EGPA in Northern Italy (opens the original)
Read excerpt
A high prevalence of the eosinophilic granulomatosis with polyangiitis (EGPA) subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has been reported in Northern Italy, according to findings from a capture-recapture study published recently in Seminars in Arthritis and Rheumatism. The researchers conducted a population-based study in the Reggio Emilia area of northern Italy. All cases that met the 2022 American College of Rheumatology/European Alliance of Associations
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Renal and Urology News, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.